Cyndya Shibao
Cyndya Shibao
Nashville, Tennessee, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long COVID Immune Profiling | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Neurologic Manifestations, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, Signs and Symptoms, autonomic nervous system disorder, long COVID-19, lung disorder, nervous system disorder, orthostatic intolerance, pneumonia, primary dysautonomia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not stated | 2026-09-25 | NCT06027255 | |
| Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, autonomic nervous system disorder, long COVID-19, lung disorder, nervous system disorder, orthostatic intolerance, pneumonia, primary dysautonomia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 2 | 2026-01-22 | NCT07189936 |